BladderBoneBreastCervicalColonEsophagealKidneyLaryngealLeukemia CancerLiverLungLymphomaMouthOvarianPancreaticProstateRectalSkinTesticularThroatUterineSleep ProblemsApnea Sleep ProblemsNeurologyNursingPulmonologyInternal MedicineOtolaryngologyBladder CancerBone CancerBrain CancerBreast CancerCervical CancerColon CancerEsophageal CancerKidney CancerLaryngeal CancerLeukemiaLiver CancerLung CancerLymphoma CancerMouth CancerOvarian CancerPancreatic CancerProstate CancerRectal CancerSkin CancerTesticular CancerThroat CancerCancerUterine CancerMental HealthBrainSleep DisorderApnea
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Sept. 29, 2015 (HealthDay News) -- An implanted cranial nerve stimulation device might improve sleep patterns and quality of life for patients with obstructive sleep apnea (OSA), according to findings presented this week at the annual meeting of the American Academy of Otolaryngology-Head & Neck Surgery, held from Sept. 27 to 30 in Dallas.
In the study, 126 participants received the implanted upper airway stimulation system. All had previously tried and failed to adhere to continuous positive airway pressure (CPAP) treatment. A total of 111 of these patients completed a 30-month follow-up evaluation.
The researchers found that treatment was effective for more than half of the patients, based on sleepiness levels, sleep-related quality of life, diminished snoring, and oxygen intake levels. And 81 percent were still routinely using the device three years out.
Study lead author B. Tucker Woodson, M.D., a professor and chief of sleep medicine at the Medical College of Wisconsin in Milwaukee, told HealthDay that many patients are unable to use CPAP successfully for various reasons. Some find it uncomfortable and can't tolerate the mask and the pressure. "It can even make their sleep worse, not better," he added. "But with this implantable device, what we've seen is an almost normalization of their sleep problems, along with a very promising level of long-term adherence."
The study was funded by the device manufacturer, Inspire Medical Systems of Maple Grove, Minn.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 31, 2022
Read this Next
Other Trending Articles